BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6320579)

  • 1. HSV 2-associated antigens in human cervical tissues before and after grafting in nude mice.
    Christenson B; Furgyik S
    Acta Obstet Gynecol Scand; 1983; 62(5):461-6. PubMed ID: 6320579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum antibodies to herpesvirus early antigens in patients with cervical carcinoma determined by anticomplement immunofluorescence technique.
    Ito H; Tsutsui F; Kurihara S; Akabayashi T; Tobe T
    Int J Cancer; 1976 Nov; 18(5):557-63. PubMed ID: 62718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunofluorescence study of the presence of herpes type 1 and type 2 antigens in patients with cancer of the uterine cervix.
    Athanasiu P; Nastac E; Stoian M; Predescu E; Hozoc M
    Virologie; 1978; 29(4):251-3. PubMed ID: 219590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Detection of herpes simplex virus antigen in human cervical carcinoma tissue].
    Xu ZH
    Zhonghua Fu Chan Ke Za Zhi; 1986 Jul; 21(4):238-41, 254. PubMed ID: 3021401
    [No Abstract]   [Full Text] [Related]  

  • 5. Herpes simplex virus II antigen in adenocarcinoma of the uterine cervix.
    Bhatia A; Ashokraj G
    Indian J Pathol Microbiol; 1988 Apr; 31(2):40-4. PubMed ID: 2844663
    [No Abstract]   [Full Text] [Related]  

  • 6. A study of herpes simplex type 2 antibody status in groups of patients with cervical neoplasia in Czechoslovakia.
    Janda Z; Kanka J; Vonka V; Svoboda B
    Int J Cancer; 1973 Nov; 12(3):626-30. PubMed ID: 4364794
    [No Abstract]   [Full Text] [Related]  

  • 7. Elution of herpes simplex virus-specific cytotoxic antibodies from squamous cell carcinoma of uterine cervix.
    Seth P; Balachandran N
    Nature; 1980 Aug; 286(5773):613-5. PubMed ID: 6250079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of herpes simplex virus type-2 antigen(s) in biopsies from carcinoma of the uterine cervix.
    Thankamani V; Kumari TV; Vasudevan DM
    J Exp Pathol; 1985; 2(2):123-33. PubMed ID: 2431113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herpesvirus type 2-induced, tumor-specific antigen in cervical carcinoma.
    Aurelian L; Davis HJ; Julian CG
    Am J Epidemiol; 1973 Jul; 98(1):1-9. PubMed ID: 4131112
    [No Abstract]   [Full Text] [Related]  

  • 10. Herpes virus-related antigens in herpes simplex virus type 2-transformed cells in the course of cervical carcinoma.
    Christenson B
    Eur J Cancer Clin Oncol; 1982 Dec; 18(12):1345-52. PubMed ID: 6299751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AG-4 complement-fixing antibodies in cervical cancer and herpes-infected patients using local herpes simplex virus type 2.
    Arsenakis M; Georgiou GM; Welsh JK; Cauchi MN; May JT
    Int J Cancer; 1980 Jan; 25(1):67-71. PubMed ID: 6249764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variations of cytotoxic antibodies to cells with herpes simplex virus antigens in women with progressing or regressing cancerous lesions of the cervix.
    Thiry L; Sprecher-Goldberger S; Fassin Y; Gould I; Gompel C; Pestiau J; De Halleux F
    Am J Epidemiol; 1974 Oct; 100(4):251-61. PubMed ID: 4370721
    [No Abstract]   [Full Text] [Related]  

  • 13. Incidence of antibody to envelope antigen of herpes simplex virus type 2 among patients with cervical carcinoma and matched controls.
    Feorino PM; Palmer EL
    J Infect Dis; 1973 Jun; 127(6):732-5. PubMed ID: 4350521
    [No Abstract]   [Full Text] [Related]  

  • 14. Virions and antigens of herpes virus type 2 in cervical carcinoma.
    Aurelian L
    Cancer Res; 1973 Jun; 33(6):1539-47. PubMed ID: 4352393
    [No Abstract]   [Full Text] [Related]  

  • 15. Cell-mediated and humoral immune responses to chlamydial and herpesvirus antigens in patients with cervical carcinoma.
    Qvigstad E; Onsrud M; Degré M; Skaug K
    Gynecol Oncol; 1985 Feb; 20(2):184-9. PubMed ID: 2982703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New antigens induced by herpes simplex virus in human tumors].
    Posevaia TA; Grigor'ev VV; Kosiakova NP; Barinskiĭ IF
    Vopr Virusol; 1981; (2):193-5. PubMed ID: 6267821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of herpes simplex virus tumor-associated antigen in uterine cervical cancer tissue: five case studies.
    Notter MF; Docherty JJ; Mortel R; Hollinshead AC
    Gynecol Oncol; 1978 Dec; 6(6):574-81. PubMed ID: 220150
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term follow-up studies on herpes simplex antibodies in the course of cervical cancer. II. Antibodies to surface antigen of Herpes simplex virus infected cells.
    Christenson B; Espmark A
    Int J Cancer; 1976 Mar; 17(3):318-25. PubMed ID: 176115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical cancer cell lines containing herpesvirus markers.
    Melnick JL; Adam E; Lewis R; Kaufman RH
    Intervirology; 1979; 12(2):111-4. PubMed ID: 231583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpesvirus antigens as markers for cervical cancer.
    Gupta PK; Aurelian L; Frost JK; Carpenter JM; Klacsmann KT; Rosenshein NB; Tyrer HW
    Gynecol Oncol; 1981 Oct; 12(2 Pt 2):S232-58. PubMed ID: 6273263
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.